Subject(s)

Scleroderma, Localized/physiopathology , Adolescent , Child , Child Development , Child, Preschool , Disabled Persons , Disease Progression , Early Diagnosis , Humans , Immunosuppressive Agents/therapeutic use , Scleroderma, Localized/diagnosis , Scleroderma, Localized/drug therapy , Scleroderma, Localized/pathology , Time-to-Treatment , Treatment Outcome